Randomised controlled trial of self-management of postnatal antihypertensive treatment

niversity of Oxford0 sites628 target enrollmentJune 11, 2024

Overview

Phase: 未知
Intervention: Not specified
Conditions: Monitoring of hypertension in women following hypertensive pregnancy
Sponsor: niversity of Oxford
Enrollment: 628
Status: Active, not recruiting
Last Updated: last year

No summary available.

Registry

who.int

Start Date

June 11, 2024

End Date

December 1, 2026

Last Updated

last year

Study Type

Interventional

Sex

Female

Sponsor

•1\. Participant is willing and able to give informed consent for participation in the study
•2\. People who have recently given birth within the last 7 days
•3\. Aged 18 years or above
•4\. Participant with pregnancy hypertension including: chronic/essential hypertension (predating current pregnancy or requiring treatment before 20/40\), or gestational hypertension (new\-onset hypertension from 20/40 of index pregnancy) or pre\-eclampsia (hypertension (GH or with proteinuria or metabolic changes), prior to their discharge from hospital post\-delivery.
•5\. Participant still requiring antihypertensive medication at randomisation following delivery
•6\. Able and willing to comply with trial requirements
•7\. Willing to allow their primary and secondary healthcare teams, if appropriate, to be notified of participation in the trial
•8\. Access to a smartphone compatible with the app

•1\. Participant does not wish to self\-monitor/self\-manage their blood pressure
•2\. Participant already taking part in another trial that might affect their anti\-hypertensive prescription